2021-01-07,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021-01-06,"Verastem Oncology Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer"
2021-01-05,Verastem Oncology to Present at the H.C. Wainwright BioConnect 2021 Conference
2020-12-29,"Who Has Been Buying Verastem, Inc. (NASDAQ:VSTM) Shares?"
2020-12-15,Verastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 and Defactinib in Previously Treated KRAS Mutant Non-Small Cell Lung Cancer
2020-12-12,Is VSTM A Good Stock To Buy Now?
2020-12-01,Verastem (VSTM) Begins Phase II Combo Study for Ovarian Cancer
2020-11-30,Verastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
2020-11-12,Does Verastem (NASDAQ:VSTM) Have A Healthy Balance Sheet?
2020-11-09,Verastem Oncology Reports Third Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-10-28,Verastem Oncology Announces New Data Published in The Lancet Oncology Supports Potential of VS-6766 as Treatment for RAS Mutant Tumors
2020-10-14,Hedge Funds Are Getting More Bullish On Verastem Inc (VSTM)
2020-10-08,Verastem (VSTM) Jumps: Stock Rises 7.1%
2020-10-06,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-09-30,Verastem Oncology Announces Closing of COPIKTRA® (duvelisib) Sale to Secura Bio
2020-09-18,"How Many Verastem, Inc. (NASDAQ:VSTM) Shares Do Institutions Own?"
2020-09-16,Verastem Oncology Announces Presentation of Updated Phase 1/2 FRAME Study Data at the 2nd Annual RAS-Targeted Drug Development Summit
2020-09-15,Is the Options Market Predicting a Spike in Verastem (VSTM) Stock?
2020-09-14,Verastem Oncology Announces Investor Conference Call to Discuss Updated Clinical Data in Low-Grade Serous Ovarian Cancer from Phase 1/2 FRAME Study
2020-09-10,Verastem Oncology to Present at Upcoming Investor Conferences
2020-08-12,Did Hedge Funds Make The Right Call On Verastem Inc (VSTM) ?
2020-08-10,Why Verastem Stock Jumped Briefly This Morning
2020-08-10,Verastem Oncology Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-08-10,Verastem Oncology Signs Definitive Agreement to Sell COPIKTRA® (duvelisib) Rights to Secura Bio to Focus on Development of VS-6766 and Defactinib in KRAS Mutant Solid Tumors
2020-07-30,Verastem (VSTM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
2020-07-06,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-06-23,Hedge Funds Never Loved Verastem Inc (VSTM) More
2020-06-22,Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of VS-6766 and Defactinib in Metastatic Uveal Melanoma
2020-05-28,Verastem Oncology to Present at the Jefferies Virtual Healthcare Conference
2020-05-19,Billionaire Steven Cohen Bets Big on These 3 Stocks
2020-05-18,Are Options Traders Betting on a Big Move in Verastem (VSTM) Stock?
2020-05-14,3 Biotech Stocks Under $4 That Could Surge Over 50%
2020-05-07,Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-05-04,Why Verastem Stock Is Rising Today
2020-05-01,Is Verastem (VSTM) Stock Outpacing Its Medical Peers This Year?
2020-04-27,Verastem Oncology Announces Preliminary Data from Investigator-initiated Study Highlighting Clinical Activity of RAF/MEK and FAK Combination in KRAS Mutant Tumors Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting I
2020-04-23,Verastem Oncology Appoints John H. Johnson to its Board of Directors
2020-04-21,Verastem Oncology Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting
2020-04-20,Verastem Oncology Announces Investor Conference Call to Discuss Clinical Data from Investigator-initiated RAF/MEK and FAK Combination Study in KRAS Mutant Solid Tumors
2020-04-15,Is the Options Market Predicting a Spike in Verastem (VSTM) Stock?
2020-04-13,Verastem Oncology Announces Presentation of Clinical Data from Investigator-initiated RAF/MEK and FAK Combination Study in KRAS Mutant Solid Tumors at the American Association for Cancer Research 2020 Virtual Annual Meeting I
2020-04-09,"INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Verastem, Inc. for Potential Breach of Fiduciary Duty Claims."
2020-04-07,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-03-30,Earnings Estimates Moving Higher for Verastem (VSTM): Time to Buy?
2020-03-19,Has Verastem (VSTM) Outpaced Other Medical Stocks This Year?
2020-03-18,Verastem Sees Hammer Chart Pattern: Time to Buy?
2020-03-11,Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results
2020-03-10,"Verastem, Inc. (VSTM) Shares March Higher, Can It Continue?"
2020-02-28,Verastem Oncology Announces New Strategic Direction to Advance Its Clinical Development Programs
2020-02-28,Verastem Oncology Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
2020-02-05,Steven Cohen Renews His Interest in Verastem
2020-01-29,Verastem Oncology Announces Dosing of First Patient in CSPCs Chinese Study Evaluating COPIKTRA® (Duvelisib) in Patients with Relapsed or Refractory Follicular Lymphoma
2020-01-21,Those Who Purchased Verastem (NASDAQ:VSTM) Shares Five Years Ago Have A 74% Loss To Show For It
2020-01-09,"Verastem In-Licenses KRAS-Focused Drug From Chugai, Stock Up"
2020-01-08,"The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results"
2020-01-08,"Verastem Oncology Announces Global Licensing Agreement with Chugai Pharmaceutical Co., Ltd. to Develop and Commercialize RAF/MEK Inhibitor CH5126766"
2020-01-06,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-12-17,Do Hedge Funds Love Verastem Inc (VSTM)?
2019-12-11,Implied Volatility Surging for Verastem (VSTM) Stock Options
2019-12-07,Verastem Oncology Presents Phase 2 PRIMO Study Data Evaluating Duvelisib in Relapsed or Refractory Peripheral T-Cell Lymphoma at the American Society of Hematology 2019 Annual Meeting
2019-11-25,Implied Volatility Surging for Verastem (VSTM) Stock Options
2019-11-25,Verastem Oncology Announces Submission of a Marketing Authorization Application to the European Medicines Agency for COPIKTRA® (duvelisib)
2019-11-15,Edited Transcript of VSTM earnings conference call or presentation 29-Oct-19 8:30pm GMT
2019-11-13,"Verastem Oncology Announces Andrei Shustov, M.D., Recipient of 2nd Annual Innovation in Care Award"
2019-11-12,Verastem Oncology Announces Private Exchange of Approximately $114.3 Million of its 5.00% Convertible Senior Notes due 2048 for 5.00% Convertible Senior Second Lien Notes Due 2048
2019-11-06,Verastem Oncology to Present Phase 2 PRIMO Study Data Evaluating Duvelisib in Relapsed or Refractory Peripheral T-Cell Lymphoma at the American Society of Hematology 2019 Annual Meeting
2019-10-30,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings"
2019-10-29,"Verastem (VSTM) Reports Q3 Loss, Misses Revenue Estimates"
2019-10-29,Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress
2019-10-23,Verastem Oncology Announces COPIKTRA (Duvelisib) Presentations at the Lymphoma & Myeloma 2019 International Congress
2019-10-17,"Verastem Oncology to Announce Third Quarter 2019 Financial Results and Corporate Update on October 29, 2019"
2019-10-09,Biotech Stock Roundup: GILD's Descovy Label Expansion Gets FDA Nod &amp; Other Updates
2019-10-08,Verastem's (VSTM) Copiktra Gets Orphan Drug Designation
2019-10-07,"Verastem Oncology Announces Dosing of First Patient in Yakult Honsha Co., Ltd.s Japanese Bridging Study Evaluating COPIKTRA® (Duvelisib) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma"
2019-10-04,"How Many Verastem, Inc. (NASDAQ:VSTM) Shares Did Insiders Buy, In The Last Year?"
2019-10-04,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-10-03,Verastem Oncology Receives Orphan Drug Designation from FDA for COPIKTRA for the Treatment of T-Cell Lymphoma
2019-10-03,Verastem Oncology Presents New Preclinical Duvelisib Data at the 5th International Conference on New Concepts in Lymphoid Malignancies
2019-09-26,Verastem Oncology to Present at the Cantor 2019 Global Healthcare Conference
2019-09-20,Verastem Oncology Announces COPIKTRA (Duvelisib) Presentations at the 18th Annual International Workshop on Chronic Lymphocytic Leukemia
2019-09-03,Verastem Oncology to Present at the 21st Annual H.C. Wainwright Global Investment Conference
2019-08-06,Edited Transcript of VSTM earnings conference call or presentation 1-Aug-19 8:30pm GMT
2019-08-05,Verastem Inc (VSTM) Q2 2019 Earnings Call Transcript
2019-08-01,"Verastem (VSTM) Reports Q2 Loss, Tops Revenue Estimates"
2019-08-01,Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
2019-07-30,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings"
2019-07-29,Verastem Oncology Appoints Brian Stuglik as Chief Executive Officer
2019-07-26,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint"
2019-07-25,"Verastem Oncology Signs an Exclusive License Agreement with Sanofi for the Development and Commercialization of COPIKTRA® (duvelisib) in Russia and CIS, Turkey, the Middle East and Africa"
2019-07-25,"Verastem Oncology to Announce Second Quarter 2019 Financial Results and Corporate Update on August 1, 2019"
2019-07-23,"What Kind Of Shareholders Own Verastem, Inc. (NASDAQ:VSTM)?"
2019-07-03,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-06-25,Hedge Funds Have Never Been This Bullish On Verastem Inc (VSTM)
2019-06-24,Verastem Up on Positive Data From Early-Stage Copiktra Study
2019-06-21,Verastem Shares Response Rate From COPIKTRA Data
2019-06-21,Verastem Oncology Presents COPIKTRA (Duvelisib) Data in Peripheral T-Cell Lymphoma at the 2019 International Conference on Malignant Lymphoma
2019-06-20,"The Zacks Analyst Blog Highlights: Incyte, Blueprint Medicines, Verastem and uniQure"
2019-06-20,Verastem Oncology Announces Leadership Changes
2019-06-19,Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal
2019-06-17,Verastem Oncology Presents COPIKTRA (Duvelisib) Data at the European Hematology Association 2019 Annual Meeting
